Trials / Conditions / Cytomegalovirus (CMV)

Cytomegalovirus (CMV)

20 registered clinical trials studyying Cytomegalovirus (CMV) — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and NCT07513623	University of California, San Francisco	Phase 2
Recruiting	A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplant NCT06243731	Takeda	—
Recruiting	Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific Antibodies NCT07014319	Seoul National University Hospital	Phase 2
Recruiting	Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients NCT06798909	University of California, San Francisco	Phase 3
Recruiting	A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium NCT06677892	Takeda	—
Recruiting	A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections NCT06439342	Takeda	Phase 3
Recruiting	A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in Sout NCT06555432	Takeda	—
Completed	A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection NCT06615921	Takeda	—
Completed	A Study of Cytomegalovirus (CMV) Infection After Kidney Transplant in Adults in the United Kingdom NCT06568055	Takeda	—
Recruiting	A Study of Maribavir in Adults and Children With Post-transplant Cytomegalovirus (CMV) Infection in Argentina NCT06213974	Takeda	—
Recruiting	A Survey of Maribavir Tablets in Participants With Cytomegalovirus Infection NCT06577363	Takeda	—
Recruiting	Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOwe NCT06793124	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Recruiting	A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the NCT05319353	Takeda	Phase 3
Completed	A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe NCT05576805	Takeda	—
Completed	A Study on Cytomegalovirus (CMV) Infection Outcomes Among Hematopoietic Stem Cell Transplant (HSCT) Participan NCT05571137	Takeda	—
Completed	A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) Infection NCT05137717	Takeda	Phase 3
Completed	A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Receive NCT02927067	Shire	Phase 3
Completed	Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Rec NCT02931539	Shire	Phase 3
Completed	Study of SHP620 (Maribavir) in Healthy Adults NCT02775240	Shire	Phase 1
Completed	Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients NCT01611974	Shire	Phase 2